Profile picture

Associate Professor Thorsten Leucker

Johns Hopkins University, Baltimore (United States of America)
Membership: ESC Professional Member
Follow
Biography
Thorsten M. Leucker, MD, PhD, is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine, where he serves as Director of the Cardiology Fellowship Program, Director of Basic and Translational Vascular Biology Research at the Ciccarone Center for the Prevention of Heart Disease, and Director of the Johns Hopkins Cardiovascular Clinical Research Unit. His clinical and research interests focus on preventive cardiology, vascular biology, and the role of inflammation and lipoprotein(a) in atherosclerotic cardiovascular disease. His translational research integrates advanced cardiovascular imaging, including PET, CT, and MRI, with mechanistic and clinical studies investigating coronary endothelial dysfunction, vascular inflammation, and emerging therapeutic strategies, particularly in people living with HIV. Dr. Leucker leads investigator-initiated studies and participates in international multicenter clinical trials evaluating novel cardiovascular therapies.
Logo ESC

Contributor content

Oxidized phospholipids (OxPLs) dynamics following acute myocardial infarction (MI): effects of PCSK9 inhibition with evolocumab
Presentation
Oxidized phospholipids (OxPLs) dynamics following acute myocardial infarction (MI): effects of PCSK9 inhibition with evolocumab
Proprotein convertase subtilisin/kexin Type 9 links inflammation to vascular endothelial cell dysfunction
Presentation
Proprotein convertase subtilisin/kexin Type 9 links inflammation to vascular endothelial cell dysfunction
Striking while the plaque is hot: emerging evidence.
Presentation
Striking while the plaque is hot: emerging evidence.
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia